Human Metabolome Project
 | The neutrality of this article is disputed. (May 2025) (Learn how and when to remove this template message) |
Human Metabolome Project
Introduction
The Human Metabolome Project (HMP) is a large-scale scientific initiative launched in 2004 to systematically identify, quantify, and catalog the complete set of small-molecule metabolites present in the human body. Conceived and led by David S. Wishart at the University of Alberta, the HMP was designed to complement earlier "omics" efforts such as the Human Genome Project (HGP) and to precede and inform subsequent initiatives such as the Human Proteome Project (HPP). Like these landmark projects, the HMP sought to build foundational scientific infrastructure by collecting comprehensive datasets, developing advanced analytical technologies, and creating accessible computational tools. Its overarching goal was to transform metabolomics into a robust, standardized, and widely accessible scientific discipline capable of supporting advances in medicine, biology, and biotechnology.[1][2]
Background and rationale
By the early 2000s, the fields of genomics and proteomics had already achieved significant progress in developing centralized databases, standardized analytical pipelines, and international collaborative frameworks. In contrast, metabolomics lagged considerably behind. Much of the available knowledge about metabolites—small molecules such as amino acids, lipids, sugars, vitamins, and xenobiotics—was dispersed across decades of biochemical literature, clinical chemistry records, and specialized databases, making it difficult to access, integrate, or analyze systematically.[3] This fragmentation hindered progress in understanding metabolism at a systems level and limited the ability of researchers to identify biomarkers or interpret metabolic changes in disease.
The metabolome occupies a unique position in biology as the downstream product of gene expression and protein activity, while also being directly influenced by environmental factors such as diet, drugs, microbiota, and lifestyle. As a result, metabolite profiles provide a highly sensitive and dynamic representation of an organism's phenotype. This dual genetic and environmental sensitivity makes metabolomics particularly valuable for studying disease mechanisms, monitoring physiological states, and identifying diagnostic biomarkers.[4] Recognizing this potential, the HMP was designed to create a comprehensive, integrated resource that would unify chemical, biological, and clinical data, thereby enabling researchers to better understand the complex interplay between genotype, environment, and phenotype.
History and funding
The Human Metabolome Project originated from a Genome Canada proposal submitted in 2003 under the title "Building the metabolomic toolbox: enabling rapid disease diagnosis through metabolic profiling".[5] This proposal emphasized the need to develop both comprehensive metabolite databases and the analytical tools required to measure metabolites accurately and efficiently in biological samples. The project was formally funded in 2004 and officially launched in January 2005, with an initial budget of approximately $7.22 million supported by Genome Canada and matching provincial and industrial contributions.[6]
Over time, the HMP expanded substantially, receiving additional funding from major Canadian agencies including the Canadian Institutes of Health Research, the Canada Foundation for Innovation, Alberta Innovates, and the Natural Sciences and Engineering Research Council. These investments brought total funding to more than $18 million, enabling sustained growth and continued innovation over two decades[1]. Unlike the multinational Human Genome Project, which involved collaborations across multiple countries and required billions of dollars in funding, the HMP was primarily a Canadian initiative centered at the University of Alberta, with contributions from collaborators across the country.[7][8] Despite its comparatively modest scale and budget, the HMP achieved an impact comparable to larger international efforts by focusing on strategic innovation, integration, and open data dissemination.
Objectives and scope
The primary objectives of the Human Metabolome Project were to identify and catalog all metabolites present in the human body above a defined concentration threshold, determine their chemical structures and concentrations, and link these metabolites to biological pathways, physiological functions, and disease states[6]. A central goal was to create a comprehensive and freely accessible database that would serve as a reference resource for the global scientific community.
In addition to database development, the HMP aimed to establish standardized nomenclature, develop metabolite identifiers, and create robust analytical methods for metabolite detection and quantification. The project also sought to integrate metabolomic data with genomic and proteomic information, thereby enabling multi-omics analyses that could provide deeper insights into biological systems. A major component of the HMP involved the systematic characterization of metabolites in key human biofluids, including serum,.[9] urine[10], cerebrospinal fluid,[11] saliva[12], and feces[13]. These studies combined experimental measurements using multiple analytical platforms—such as nuclear magnetic resonance spectroscopy, liquid chromatography–mass spectrometry, and gas chromatography–mass spectrometry—with extensive computer-aided literature mining to maximize metabolite coverage and ensure data accuracy[9][10][11][12][13]
Major accomplishments
Human Metabolome Database
The most significant and widely recognized output of the Human Metabolome Project is the Human Metabolome Database (HMDB), first released in 2007. The HMDB serves as a comprehensive repository of detailed information about human metabolites, including their chemical structures, physical and chemical properties, biological roles, physiological concentrations, disease associations, and reference spectral data.[14] Each metabolite entry in the database contains extensive annotations, often encompassing dozens of data fields, as well as links to external resources and scientific literature.
Over the years, the HMDB has undergone continuous expansion and refinement. By 2022, it contained information on more than 217,000 metabolites, along with millions of associated spectra and extensive pathway data[4]. This growth reflects both advances in analytical technology and the incorporation of computational predictions, including predicted spectra and structural data. The HMDB is widely regarded as the most comprehensive organism-specific metabolomics database in the world and has become an essential resource for researchers in metabolomics, clinical chemistry, pharmacology, and systems biology.
Biofluid metabolome characterization
Another major accomplishment of the HMP was the systematic characterization of the metabolomes of key human biofluids. These studies provided detailed inventories of metabolites present in serum, urine, cerebrospinal fluid, saliva, and feces, along with quantitative concentration data and disease associations. For example, the human serum metabolome study identified thousands of compounds and established reference concentration ranges for many metabolites, while the urine metabolome study cataloged over 2,600 metabolites, significantly expanding the known diversity of urinary compounds[9][10].[15]
Similarly, the characterization of the cerebrospinal fluid metabolome provided important insights into the biochemical composition of this clinically significant biofluid and its relevance to neurological diseases[11]. Studies of saliva and fecal metabolomes further extended the scope of the project, highlighting the diagnostic potential of non-invasive sampling methods and the importance of the microbiome in shaping human metabolism.[12][13] Together, these studies established a comprehensive baseline for human metabolite composition and variability across different biological matrices.
Quantitative metabolomics and standards
A distinguishing feature of the HMP was its emphasis on absolute quantification of metabolites, rather than relative or semi-quantitative measurements. By integrating multiple analytical platforms and methodologies, researchers were able to generate highly accurate concentration data for hundreds to thousands of metabolites in biological samples.[16] This approach represented a significant advancement over earlier metabolomic studies, which often lacked reproducibility and standardization.
The development of quantitative reference datasets, such as those generated for standardized plasma samples, provided critical benchmarks for the metabolomics community. These datasets enabled researchers to calibrate their instruments, validate their methods, and compare results across studies, thereby improving the reliability and reproducibility of metabolomic analyses. The HMP's focus on standardization and quality control helped establish best practices that continue to guide the field.
Software and analytical tools
In addition to experimental and database contributions, the HMP led to the development of a range of computational tools designed to facilitate metabolomic data analysis. Among these, MetaboAnalyst has become one of the most widely used platforms for statistical analysis, visualization, and interpretation of metabolomic data[3].[17] These tools enabled researchers to process complex datasets, identify patterns, and generate biological insights without requiring extensive computational expertise.
The integration of software tools with comprehensive databases such as the HMDB created a powerful ecosystem for metabolomics research. This ecosystem allowed users to perform tasks such as metabolite identification, pathway analysis, and biomarker discovery in a streamlined and accessible manner. By democratizing access to advanced analytical capabilities, the HMP significantly broadened participation in metabolomics research and accelerated scientific discovery.
Comparison with other "omics" projects
The Human Metabolome Project is frequently compared with the Human Genome Project and the Human Proteome Project, both of which represent major milestones in the development of systems biology. While the HGP focused on sequencing the human genome and required billions of dollars in funding, and the HPP aims to catalog all human proteins with similarly large investments, the HMP achieved a transformative impact with a comparatively modest budget.[3][8]
One of the key distinctions between these projects lies in the nature of their respective targets. The genome is relatively static and uniform across individuals, while the proteome is dynamic and varies with cellular conditions. The metabolome, however, is even more dynamic and directly reflects both genetic and environmental influences. This makes metabolomics uniquely suited for studying real-time physiological changes and for capturing the effects of diet, lifestyle, and environmental exposures[4]. By providing detailed information on metabolite concentrations and interactions, the HMP offers a critical bridge between genotype and phenotype, complementing the insights gained from genomic and proteomic studies.
Impact and legacy
The Human Metabolome Project has had a profound and lasting impact on the field of metabolomics and on the broader life sciences. By establishing comprehensive data resources, standardized methodologies, and accessible analytical tools, it transformed metabolomics from a fragmented and relatively niche discipline into a central component of systems biology.[18] The HMP's contributions have enabled advances in a wide range of applications, including biomarker discovery, precision medicine, toxicology, nutrition, and environmental health.[19][20]
The project also laid the groundwork for subsequent initiatives in exposomics and multi-omics integration, where metabolomic data are combined with genomic, proteomic, and transcriptomic information to provide a more complete understanding of biological systems. Its emphasis on open access and data sharing has influenced scientific practices across disciplines, promoting transparency, collaboration, and reproducibility.
Conclusion
The Human Metabolome Project[21] represents a landmark achievement in modern biology, demonstrating how targeted investment in data infrastructure, technology development, and open science can transform an emerging field. By systematically cataloging the chemical components of the human body and linking them to biological function and disease, the HMP has provided an essential resource for researchers worldwide. Its success highlights the importance of integrating diverse data types and underscores the critical role of metabolomics in bridging the gap between genotype and phenotype. As the field continues to evolve, the legacy of the HMP will remain central to efforts aimed at understanding human health and disease at a systems level.
References
- ↑ 1.0 1.1 Wishart DS, Greiner R, Bamforth F, Li L, Marrie T, Sykes BD, Vogel H, Clive D. The Human Metabolome Project: history and overview. University of Alberta internal documents; 2003–2026.
- ↑ Ph.D, Dr Sanchari Sinha Dutta (2020-02-14). "The Human Metabolome Project". AZoLifeSciences. Retrieved 2026-05-06.
- ↑ 3.0 3.1 3.2 Wishart, David S (2007). "Proteomics and the Human Metabolome Project". Expert Review of Proteomics. 4 (3): 333–335. doi:10.1586/14789450.4.3.333. ISSN 1478-9450. PMID 17552914.
- ↑ 4.0 4.1 4.2 Wishart, David S; Guo, AnChi; Oler, Eponine; Wang, Fei; Anjum, Afia; Peters, Harrison; Dizon, Raynard; Sayeeda, Zinat; Tian, Siyang; Lee, Brian L; Berjanskii, Mark; Mah, Robert; Yamamoto, Mai; Jovel, Juan; Torres-Calzada, Claudia (2022-01-07). "HMDB 5.0: the Human Metabolome Database for 2022". Nucleic Acids Research. 50 (D1): D622–D631. doi:10.1093/nar/gkab1062. ISSN 0305-1048. PMC 8728138 Check
|pmc=value (help). PMID 34986597 Check|pmid=value (help). - ↑ "Building the Metabolomics Toolbox: Enabling Rapid Disease Diagnosis through Metabolic Profiling". GenomeCanada. Retrieved 2026-05-06.
- ↑ 6.0 6.1 Wishart DS, Mandal R, Knox C, Guo AC, Eisner R, Young N, Hau DD. Human Metabolome Project summary and objectives. Genome Canada Reports; 2005–2015.
- ↑ "Alberta scientists map human metabolome chemicals". CBC/Radio-Canada. January 24, 2007. Retrieved May 5, 2026.
- ↑ 8.0 8.1 "Canadian Researchers First To Complete The Human Metabalome". ScienceDaily. Retrieved 2026-05-06.
- ↑ 9.0 9.1 9.2 Psychogios, Nikolaos; Hau, David D.; Peng, Jun; Guo, An Chi; Mandal, Rupasri; Bouatra, Souhaila; Sinelnikov, Igor; Krishnamurthy, Ramanarayan; Eisner, Roman; Gautam, Bijaya; Young, Nelson; Xia, Jianguo; Knox, Craig; Dong, Edison; Huang, Paul (2011-02-16). Flower, Darren, ed. "The Human Serum Metabolome". PLOS ONE. 6 (2): e16957. Bibcode:2011PLoSO...616957P. doi:10.1371/journal.pone.0016957. ISSN 1932-6203. PMC 3040193. PMID 21359215.
- ↑ 10.0 10.1 10.2 Bouatra, Souhaila; Aziat, Farid; Mandal, Rupasri; Guo, An Chi; Wilson, Michael R.; Knox, Craig; Bjorndahl, Trent C.; Krishnamurthy, Ramanarayan; Saleem, Fozia; Liu, Philip; Dame, Zerihun T.; Poelzer, Jenna; Huynh, Jessica; Yallou, Faizath S.; Psychogios, Nick (2013-09-04). Dzeja, Petras, ed. "The Human Urine Metabolome". PLOS ONE. 8 (9): e73076. Bibcode:2013PLoSO...873076B. doi:10.1371/journal.pone.0073076. ISSN 1932-6203. PMC 3762851. PMID 24023812.
- ↑ 11.0 11.1 11.2 Mandal, Rupasri; Guo, An Chi; Chaudhary, Kruti K; Liu, Philip; Yallou, Faizath S; Dong, Edison; Aziat, Farid; Wishart, David S (2012-04-30). "Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update". Genome Medicine. 4 (4). doi:10.1186/gm337. ISSN 1756-994X. PMC 3446266. PMID 22546835. Unknown parameter
|article-number=ignored (help) - ↑ 12.0 12.1 12.2 Dame, Zerihun T; Aziat, Farid; Mandal, Rupasri; Krishnamurthy, Ram; Bouatra, Souhaila; Borzouie, Shima; Guo, An Chi; Sajed, Tanvir; Deng, Lu; Lin, Hong; Liu, Philip; Dong, Edison; Wishart, David S. (2015). "The human saliva metabolome". Metabolomics. 11 (6): 1864–1883. doi:10.1007/s11306-015-0840-5. ISSN 1573-3882.
- ↑ 13.0 13.1 13.2 Karu, Naama; Deng, Lu; Slae, Mordechai; Guo, An Chi; Sajed, Tanvir; Huynh, Hien; Wine, Eytan; Wishart, David S. (2018). "A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database". Analytica Chimica Acta. 1030: 1–24. Bibcode:2018AcAC.1030....1K. doi:10.1016/j.aca.2018.05.031. PMID 30032758.
- ↑ Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M.-A.; Forsythe, I. (2007-01-03). "HMDB: the Human Metabolome Database". Nucleic Acids Research. 35 (Database): D521–D526. doi:10.1093/nar/gkl923. ISSN 0305-1048. PMC 1899095. PMID 17202168.
- ↑ "Researchers find the key to what's in our pee". www.ualberta.ca. Retrieved 2026-05-06.
- ↑ Mandal, Rupasri; Zheng, Jiamin; Zhang, Lun; Oler, Eponine; LeVatte, Marcia A.; Berjanskii, Mark; Lipfert, Matthias; Han, Jun; Borchers, Christoph H.; Wishart, David S. (2025-01-14). "Comprehensive, Quantitative Analysis of SRM 1950: the NIST Human Plasma Reference Material". Analytical Chemistry. 97 (1): 667–675. Bibcode:2025AnaCh..97..667M. doi:10.1021/acs.analchem.4c05018. ISSN 0003-2700. PMC 11740895 Check
|pmc=value (help). PMID 39757418 Check|pmid=value (help). - ↑ Xia, J.; Psychogios, N.; Young, N.; Wishart, D. S. (2009-07-01). "MetaboAnalyst: a web server for metabolomic data analysis and interpretation". Nucleic Acids Research. 37 (Web Server): W652–W660. doi:10.1093/nar/gkp356. ISSN 0305-1048. PMC 2703878. PMID 19429898.
- ↑ Wishart, David (2012), Suhre, Karsten, ed., "Systems Biology Resources Arising from the Human Metabolome Project", Genetics Meets Metabolomics, New York, NY: Springer New York, pp. 157–175, doi:10.1007/978-1-4614-1689-0_11, ISBN 978-1-4614-1688-3, retrieved 2026-05-06
- ↑ Rollans, Scott. "New Horizons in Health Care". www.ualberta.ca. Retrieved 2026-05-06.
- ↑ Willis, Katie. "When Medicine Is Designed Just for You". www.ualberta.ca. Retrieved 2026-05-06.
- ↑ "History and Legacy of the Human Metabolome Project". humanmetabolomeproject.ca. Retrieved 2026-05-06.
This article "Human Metabolome Project" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Human Metabolome Project. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
